CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $15.34B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.57: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.92%Below 5Y avg (1.23%)
Annual Rate
EUR 0.72Paid annual
Payout Ratio
25.0%Sustainable
Last Ex-Dividend
Apr 28, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.36BEUR15.34B · vs all stocks (USD)
Trailing P/E
26.54xvs Diagnostics & Research peers
Revenue (TTM)
7.39BEUR8.48B · vs all stocks (USD)
Profit Margin
7.17%vs Diagnostics & Research peers
Beta
0.8480xvs all stocks
52-Week Change
24.54%vs all stocks
Market Capitalization
13.36BEUR15.34B · vs all stocks (USD)
Enterprise Value
17.16BEUR19.70B · vs all stocks (USD)
Trailing P/E
26.54xvs Diagnostics & Research peers
Forward P/E
16.34xvs Diagnostics & Research peers
Price to Sales (TTM)
1.77xvs Diagnostics & Research peers
Price to Book (MRQ)
3.67xvs Diagnostics & Research peers
Enterprise to Revenue
2.32xvs Diagnostics & Research peers
Enterprise to EBITDA
11.16xvs Diagnostics & Research peers
Profit Margin
7.17%vs Diagnostics & Research peers
Operating Margin
16.17%vs Diagnostics & Research peers
Return on Assets (TTM)
5.99%vs Diagnostics & Research peers
Return on Equity (TTM)
11.33%vs Diagnostics & Research peers
Revenue (TTM)
7.39BEUR8.48B · vs all stocks (USD)
Revenue per Share (TTM)
41.84EURUpdated Sep 21, 2026Quarterly Revenue Growth
2.50%vs Diagnostics & Research peers
Gross Profit (TTM)
1.71BEUR1.96B · vs all stocks (USD)
EBITDA (TTM)
1.58BEUR1.81B · vs all stocks (USD)
Net Income (TTM)
469.90MEUR539.64M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
22.20%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
1.49BEUR1.71B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
339.56MEUR389.96M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.7200EURUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.92%vs all stocks
5-Year Average Dividend Yield
1.23%vs all stocks
Payout Ratio
25.00%vs Diagnostics & Research peers
Minority Interest (Equity)
33.40MEURFY2025 · Dec 31, 2025Revenue
7.30BEURFY2025 · Dec 31, 2025Cost of Goods Sold
2.33BEURFY2025 · Dec 31, 2025Gross Profit
4.97BEURFY2025 · Dec 31, 2025Operating Income
818.30MEUR939.74M · vs all stocks (USD)
Pre-tax Income
654.10MEURFY2025 · Dec 31, 2025Income Tax Expense
181.10MEURFY2025 · Dec 31, 2025Net Income
473.00MEURFY2025 · Dec 31, 2025EBIT
811.20MEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.58BEURFY2025 · Dec 31, 2025Other Operating Expenses
58.60MEURFY2025 · Dec 31, 2025Non-operating Interest Income
10.60MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
157.10MEURFY2025 · Dec 31, 2025EPS (Basic)
2.64EURFY2025 · Dec 31, 2025EPS (Diluted)
2.55EURFY2025 · Dec 31, 2025Basic Shares Outstanding
179.80MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
179.80MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
1.80MEURFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025Operating Cash Flow
893.70MEURFY2025 · Dec 31, 2025Free Cash Flow
148.00MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
787.80MEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
654.10MEURFY2025 · Dec 31, 2025Stock-based Compensation
138.10MEURFY2025 · Dec 31, 2025Other Non-cash Items
105.30MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-44.50MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
40.70MEURFY2025 · Dec 31, 2025Capital Expenditures
-745.70MEURFY2025 · Dec 31, 2025Net Intangibles (CF)
-74.90MEURFY2025 · Dec 31, 2025Net Acquisitions
-264.20MEURFY2025 · Dec 31, 2025Other Investing Activity
-100.00KEURFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.01BEURFY2025 · Dec 31, 2025Long-term Debt Issuance
1.22BEURFY2025 · Dec 31, 2025Long-term Debt Payments
-310.90MEURFY2025 · Dec 31, 2025Common Stock Repurchase
-541.30MEURFY2025 · Dec 31, 2025Common Dividends Paid
-107.70MEURFY2025 · Dec 31, 2025Other Financing Charges
-51.90MEURFY2025 · Dec 31, 2025Net Financing Cash Flow
210.00MEURFY2025 · Dec 31, 2025Shares Outstanding
176.70MSharesUpdated Sep 21, 2026Float Shares
110.07MSharesUpdated Sep 21, 2026% Held by Insiders
36.50%vs all stocks
% Held by Institutions
34.10%vs all stocks
Total Cash (MRQ)
617.80MEUR709.49M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.56EURUpdated Sep 21, 2026Total Debt (MRQ)
4.47BEUR5.14B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.9612xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.13xvs Diagnostics & Research peers
Book Value per Share (MRQ)
20.85EURUpdated Sep 21, 2026Total Assets
10.99BEUR12.62B · vs all stocks (USD)
Total Current Assets
2.65BEURFY2025 · Dec 31, 2025Total Liabilities
6.41BEURFY2025 · Dec 31, 2025Total Non-current Assets
8.33BEURFY2025 · Dec 31, 2025Total Non-current Liabilities
3.98BEURFY2025 · Dec 31, 2025Total Current Liabilities
2.43BEURFY2025 · Dec 31, 2025Cash
539.60MEURFY2025 · Dec 31, 2025Cash Equivalents
251.60MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
791.20MEURFY2025 · Dec 31, 2025Accounts Receivable
1.10BEURFY2025 · Dec 31, 2025Inventory
139.30MEURFY2025 · Dec 31, 2025Accounts Payable
678.10MEURFY2025 · Dec 31, 2025Short-term Debt
726.70MEURFY2025 · Dec 31, 2025Other Current Liabilities
100.00KEURFY2025 · Dec 31, 2025Long-term Debt
3.71BEURFY2025 · Dec 31, 2025Other Non-current Liabilities
100.00KEURFY2025 · Dec 31, 2025Common Stock (Book)
1.80MEURFY2025 · Dec 31, 2025Retained Earnings
3.02BEURFY2025 · Dec 31, 2025Total Shareholders' Equity
4.58BEUR5.26B · vs all stocks (USD)
Treasury Stock
298.90MEURFY2025 · Dec 31, 202552-Week Low
54.86EURUpdated Sep 21, 202652-Week High
78.54EURUpdated Sep 21, 202652-Week Change
24.54%vs all stocks
Beta
0.8480xvs all stocks
50-Day MA
70.84EURUpdated Sep 21, 2026200-Day MA
66.29EURUpdated Sep 21, 2026Avg 10-Day Volume
459.29KSharesUpdated Sep 21, 2026Avg 30-Day Volume
296.87KSharesUpdated Sep 21, 2026Diluted EPS (TTM)
2.88EURUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.57: grey zoneSignificant
Altman Z-Score: 2.57
High earnings qualityNotable
Earnings Quality Score: 1.61
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $15.34B, above the global median of $1.18BNotable
Market cap (USD): 15,339,335,091.292Global Median: 1,180,223,658.953
Revenue is $8.48B, above the global median of $548.88MNotable
Revenue (USD): 8,481,582,238.746Global Median: 548,883,780.48
Levered free cash flow is $389.96M, above the global median of $18.73MNotable
Levered free cash flow (USD): 389,956,966.031Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Han's Laser Technology Industry Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Phison Electronics Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Solventum Corporation
Tier 1ProductionThroughput-Bound ConversionRule
Datang International Power Generation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Robotechnik Intelligent Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
James Hardie Industries plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
China Three Gorges Renewables (Group) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Will Semiconductor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Sinoma Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ball Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule